1/3 Is tolvaptan's kidney "benefit" in ADPKD a measurement artifact?
New paper: high water intake → less eating → muscle loss → lower creatinine → falsely "preserved" eGFR. ~1%/yr muscle change could explain the TEMPO3:4 effect.
Cystatin C measured but never reported. Why?
New paper: high water intake → less eating → muscle loss → lower creatinine → falsely "preserved" eGFR. ~1%/yr muscle change could explain the TEMPO3:4 effect.
Cystatin C measured but never reported. Why?